| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Gerardo Rosati | |
| Domenico Bilancia | |||
| P2860 | cites work | Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer | Q27860681 |
| Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial | Q28036747 | ||
| Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer | Q29616236 | ||
| Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients | Q33368070 | ||
| Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial | Q33369393 | ||
| XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer | Q33370632 | ||
| Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer | Q33372496 | ||
| Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer | Q33913953 | ||
| The application of the principles of geriatrics to the management of the older person with cancer | Q34014908 | ||
| Chemotherapy in elderly patients with colorectal cancer | Q34277764 | ||
| Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale | Q34425278 | ||
| Capecitabine as adjuvant treatment for stage III colon cancer | Q34429990 | ||
| Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group | Q34511070 | ||
| Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study | Q34514696 | ||
| Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial | Q34555503 | ||
| Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity | Q36292188 | ||
| Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials | Q36460967 | ||
| Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer | Q37425689 | ||
| Clinical pharmacology of 5-fluorouracil | Q38631279 | ||
| Single-agent irinotecan as second-line weekly chemotherapy in elderly patients with advanced colorectal cancer. | Q40467714 | ||
| Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors study. | Q40507956 | ||
| Advanced colorectal cancer in elderly patients: tolerance and efficacy of leucovorin and fluorouracil bolus plus continuous infusion. | Q43573107 | ||
| A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients | Q43763447 | ||
| Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders | Q44150789 | ||
| First-line chemotherapy with fluorouracil and folinic acid for advanced colorectal cancer in elderly patients: a phase II study | Q44318064 | ||
| Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. | Q44919656 | ||
| Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials | Q45023406 | ||
| A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108. | Q45231756 | ||
| Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials | Q45287822 | ||
| High activity and reduced neurotoxicity of bi-fractionated oxaliplatin plus 5-fluorouracil/leucovorin for elderly patients with advanced colorectal cancer | Q46453492 | ||
| Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study | Q46648452 | ||
| Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group. | Q50956129 | ||
| Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. | Q51960759 | ||
| Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. | Q53537752 | ||
| Oxaliplatin: mechanism of action and antineoplastic activity | Q60641680 | ||
| Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer | Q61868308 | ||
| UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients | Q61917286 | ||
| Influence of sex and age on fluorouracil clearance | Q68160118 | ||
| Mechanism-based improvement in the therapeutic selectivity of 5-FU prodrug alone and under conditions of metabolic modulation | Q71934546 | ||
| Drug-company decision to end cancer trial | Q73048641 | ||
| Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study | Q73544195 | ||
| A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma | Q74635392 | ||
| UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer | Q77758522 | ||
| Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites | Q78074734 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 1812-1822 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Role of chemotherapy and novel biological agents in the treatment of elderly patients with colorectal cancer | |
| P478 | volume | 14 |
| Q45378019 | Combination therapy for older men with colorectal cancer: are two drugs better than one? | cites work | P2860 |
Search more.